An Exploratory Phase I Randomized, Single-site, Double-blind, Active-controlled, Parallel-group, Single-administration, Dose-escalation Trial to Investigate the Safety and Tolerability of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine), in Perineural Administrations for Brachial Plexus Blockade in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2018
At a glance
- Drugs Neosaxitoxin (Primary) ; Bupivacaine
- Indications Anaesthesia
- Focus Adverse reactions
- Sponsors Grunenthal
- 09 Oct 2018 Status changed from recruiting to discontinued.
- 31 Jan 2018 Status changed from not yet recruiting to recruiting.
- 22 Jan 2018 New trial record